ArticleCureus2025
Accelerated Intermittent Theta Burst Stimulation (iTBS) for Crisis Stabilization in a Transgender Adolescent with Treatment-Resistant Depression: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transgender adolescents experience disproportionately high rates of depression and suicidality, yet effective interventions for those unresponsive to conventional treatments remain scarce. This case report describes the case of a 15-year-old transgender male with severe treatment-resistant depression and active suicidal ideation who underwent an accelerated intermittent theta burst stimulation (iTBS) protocol: 20 sessions over four consecutive days targeting the left dorsolateral prefrontal cortex. Baseline scores indicated severe depression (Patient Health Questionnaire-9 (PHQ-9) = 22) and high suicide risk (Suicidal Ideation Attributes Scale (SIDAS) = 35). At the one-month follow-up, the patient's symptoms improved to minimal depression (PHQ-9 = 4) and below the high-risk suicide cutoff (SIDAS = 10). He reported improved mood, reduced suicidal thoughts, and no adverse effects. To the author's knowledge, this is the first published case of accelerated iTBS in a transgender adolescent demonstrating rapid and substantial symptom reduction with good tolerability. These findings suggest accelerated iTBS may be a safe and time-sensitive option for crisis stabilization in transgender youth when traditional approaches fail, warranting further research in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.